What the studies found in blood and cells
What can CJC-1295 research tell you about your health?
Researchers checked growth hormone in people, rats, and rat cells. CJC-1295 changed blood levels, but the later human test stopped. The missing proof matters to you.
How did CJC-1295 make the gland release more hormone?
Your growth gland sits under the brain. It releases growth hormone in short bursts, mostly while you sleep. That hormone affects growth and the upkeep of body tissue. CJC-1295 copies the body's message that starts those bursts [01]. The drug doesn't contain growth hormone; your gland releases its own supply.
A receptor is a docking spot on the outside of a cell. CJC-1295 and the body's natural message can both attach to this receptor on a growth-gland cell [20]. Once either one attaches, the cell releases stored growth hormone [05]. In 2020, scientists mapped the receptor's shape and showed how the natural message fits [05]. The receptor map explains a step inside a cell, not what a patient will feel. A 2025 review says related drugs use the same receptor [20]. Sharing a receptor doesn't prove that any drug will help you.
I'd keep one limit in view. Stage 1, the first small human test, found that the drug made the hormone bursts larger. Those blood tests can't tell you what you'd notice each day or whether your health would improve.
The rise was real in blood. A health gain wasn't shown.
How long did each kind of hormone burst last?
CJC-1295 makes the gland under your brain release more growth hormone. The long form kept its message going for days. The short form caused one burst lasting 60-90 minutes. Sermorelin, a related drug that gives the gland a similar message, caused a 15-20 minute burst [13].
Those group times can't predict how your gland would respond.
Why does long-form CJC-1295 stay longer than short-form CJC-1295?
Both forms of CJC-1295 share one main chain. The long form alone carries a part that joins a blood protein.
That protein is albumin, which transports many substances in your blood [02][12]. About half the albumin takes close to 19 days to leave your body. While CJC-1295 is attached, your kidneys are less likely to remove it. In healthy adults during stage 1, half the drug was still present across a 5.8- to 8.1-day span. Both insulin-like growth factor and growth hormone stayed high for six to eleven days after one shot [01].
In rats, CJC-1295 attached to albumin appeared in blood within 15 minutes. It was still present after 72 hours [03][14]. In rat growth-gland cells kept in a dish, CJC-1295 caused four times more growth hormone release during a two-hour test than the natural message. Of three forms, CJC-1295 worked best in that dish [03]. This isn't a finding about benefit or a safe amount for you.
Rat blood and cells can't show what you'd feel or which harm you might face.
How fast does short-form CJC-1295 leave the blood?
Short-form CJC-1295 can't attach to albumin. Half left your blood in about 30 minutes. With sermorelin, an older drug that gives your growth gland a similar message, half was gone in less than ten minutes [04][13]. The changes in the short form slow that early breakdown.
Each day, studies used several skin shots. Each shot held 100-500 micrograms, a tiny weight. People received one to three shots daily [13]. That's a study record, not your plan. Each shot led to a growth hormone burst lasting about 60-90 minutes. The long form kept working for days.
The two study schedules can't be swapped, and neither was made for your health.
Why do some papers call the short form modified GRF?
GRF stands for growth-hormone-releasing factor, your body's message telling the gland to release growth hormone. Some papers call short-form CJC-1295 modified GRF because scientists changed four spots so it wouldn't break down as fast [02]. Longer names may still mean the short form.
DAC stands for Drug Affinity Complex, the maker's name for the albumin-binding part on long-form CJC-1295. DAC isn't on the short form.
When you read a time claim, check which version—long or short—the paper means.
Which blood hormones rose after CJC-1295?
Stage 1, the first human testing stage, gave healthy adults one skin shot of up to 250 micrograms per kilogram. Average growth hormone rose two- to ten-fold for six days or longer [01]. In stage 1, insulin-like growth factor, a liver-made hormone that helps tissue grow, rose 1.5- to 3-fold through days nine to eleven [01]. In a second stage 1 group, insulin-like growth factor stayed above its starting level for up to 28 days [01].
A separate study used rat growth-gland cells in a dish. Over two hours, CJC-1295 caused four times more growth hormone release than your body's natural message [03]. The cells still released the hormone in bursts [01]. This didn't happen in people and doesn't show that you'd feel better.
No medical journal has printed the stage 2 results. ConjuChem, the drug company, enrolled about 192 adults with HIV and extra fat around their organs. Weekly amounts rose from 60-240 micrograms per kilogram [18]. The stage 1 paper had checked blood changes only. The later test stopped early, so its findings on body shape and organ fat aren't available.
Stage 1 human studies show a blood change. They don't tell you what to expect for your health.
What did each year of CJC-1295 research add?
In 2005, researchers tested rats and rat growth-gland cells, finding that CJC-1295 joined a blood protein, remained in rat blood, and made the gland cells release more growth hormone during the test. Of three forms, CJC-1295 had the strongest effect [03]. No person took part, so you can't learn what you'd feel from it.
In 2006, the main human paper covered two stage 1 studies with healthy adults. Half the drug remained for a 5.8- to 8.1-day span. Growth hormone rose two- to ten-fold. Insulin-like growth factor rose 1.5- to 3-fold. With repeat shots in stage 1, researchers followed that hormone for a 28-day period [01]. The stage 1 findings were blood results, not proof of better health for you.
In 2010, a lab found CJC-1295 in a seized drug sample [08]. In 2019, another lab found the long form attached to a protein in horse blood [09]. That horse test was meant to catch banned use in racing. In 2021, a review described a urine test that could find a tiny trace [19]. Sports officials ban the drug, and approved sports labs can test for it [15]. Detection tests don't show that the drug works, stays safe, or changes how you feel.
Finding the drug in a sample isn't the same as helping you.
How soon did each blood hormone change?
During stage 1, growth hormone bursts grew within 24 to 48 hours after one skin shot in healthy adults. They stayed high for six to nine days. Insulin-like growth factor rose more slowly and stayed high through days nine to eleven [01].
Stage 1 studies with repeat shots ran for 28- to 49-day periods. In stage 1, weekly or every-other-week amounts of 30-60 micrograms per kilogram kept insulin-like growth factor above its starting level [01]. No human paper reported a change in body shape.
These times are group averages. You can't assume your body would follow the same clock.
How does CJC-1295 differ from Ipamorelin, another hormone drug?
CJC-1295 copies one message for the growth gland. Ipamorelin is a different drug that copies another body message [10]. Each drug attaches to a different receptor, or docking spot, on the cell. Both routes can make the gland release growth hormone [05][10].
In a study with men, researchers tested the two kinds of message together. The men's blood showed more growth hormone than with either one alone [10]. This helps explain why the names appear together, but the test didn't prove that this drug pair helps you.
Your doctor can't judge the pair from that study. Evidence from people with your health is still missing.
Which blood checks did the human studies use?
In 2006, stage 1 studies asked 3 questions after healthy adults got each shot. Researchers checked how hormones changed, how long the drug stayed in blood, and what harm occurred [01]. They also measured insulin-like growth factor binding protein, which carries insulin-like growth factor in blood. That check helped show how your growth system responds.
The stage 2 study used scans to measure fat around the organs of adults with HIV. Its findings weren't printed [18].
The studies didn't ask how people felt. They can't predict what you'd notice or guide your doctor.
Were the studies done in people, animals, or cells?
In 2006, healthy adults received CJC-1295 in stage 1, the first small human tests [01]. Researchers tracked growth hormone in their blood. Stage 2 enrolled adults with HIV and extra fat around their organs [18]. You weren't in either group.
A study in rats and rat cells found that CJC-1295 attached to albumin in blood and made growth-gland cells release hormone [03][14]. Other animal work looked at muscle, bone, and fat. Animal findings can't tell you what would happen in your body.
No stage 1 paper found a useful change in blood testosterone. In stage 1, the drug acted through the growth gland, not the glands that control sex hormones [01].
There still isn't proof for someone with your age, health, and medicines.